Richard Weindruch;Angela Mastaloudis;Mark Bartlett;Scott B. Ferguson;Tomas Alberto Prolla;Jamie Louis Barger;Steve Wood
发明人:
Angela Mastaloudis,Steve Wood,Jamie Louis Barger,Richard Weindruch,Tomas Alberto Prolla,Mark Bartlett,Scott B. Ferguson
申请号:
US13420547
公开号:
US20130071369A1
申请日:
2012.03.14
申请国别(地区):
US
年份:
2013
代理人:
摘要:
An oral formulation includes a plurality of agents that promote cellular detoxification. Agents can be included that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject, wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants, and at least one gene encoding cellular detoxifiers. In addition, at least one of the plurality of agents attenuates inflammation.